Lithium ratio, phospholipids and the incidence of side effects

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Mar;18(2):285-93. doi: 10.1016/0278-5846(94)90060-4.

Abstract

The main aims of our Lithium Centre, which has been operating since 1985, are as follows: 1. the treatment of affective disorders and particularly the recurrent ones; 2. the emphasis of the Li-ratio as a predictive index of therapeutic effects on the one hand, and of the appearance of side effects on the other hand; 3. the prevention and pharmacological control of side effects and research about their mechanism of arising.; 4. organization of a computerized bibliographic service.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Drug Carriers
  • Female
  • Humans
  • Hypothalamus / metabolism
  • Liposomes
  • Lithium / administration & dosage
  • Lithium / adverse effects
  • Lithium / therapeutic use*
  • Male
  • Middle Aged
  • Mood Disorders / drug therapy*
  • Mood Disorders / psychology
  • Phospholipids / pharmacokinetics*
  • Prognosis
  • Psychiatric Status Rating Scales
  • Water-Electrolyte Balance / drug effects

Substances

  • Drug Carriers
  • Liposomes
  • Phospholipids
  • Lithium